ETV6 and precursor B-cell acute lymphoblastic leukemia: Therefore, based on the existing knowledge, it can be assumed that those secondary mutations that have been associated with another B-ALL subgroup could be present as “second hit” mutations in the ETV6::RUNX group and have similar diagnostic and clinical implications.